Valutazione Uroflussometrica Dopo Trattamento Combinato Confenossibenzamina E Cloruro Di Betanecolo

Bissada N. K. , Finkbeiner A. E. , Welch L. T. : Lower urinary tract pharmacology. III. Neuro pharmacologic basis for lower urinary tract dynamics. Urology, 9; 357–363 (1977).

Boreham P. F. , Braithwaite P. , Milewiski P. , Pearson H. : Alpha-adrenergic blockers in prostatism. Brit. J. Surg., 64; 756–757 (1977).

Caine M. , Pfau A. , Perlberg S. : The use of alpha-adrenergic blockers in benign prostatic obstruction. Brit. J. Urol., 48; 255–263 (1976).

Caine M. , Perlberg S. : Dynamics of acute retention in prostatic patient and role of adrenergic receptors. Urology, 9; 399–403 (1977).

Caine M. , Perlberg S. , Meretyk S. : A placebo-controlled double-blind study of the effect of Phenoxybenzamine in benign prostatic obstruction. Brit. J. Urol., 50; 551–554 (1978).

Caine M. : Phenoxybenzamine for benign prostatic hypertrophy. Comp. Ther., 5; 7–11 (1979).

Caine M. : Can benign hypertrophy of the prostate be treated medically? Ann. Urol., 13; 159–165 (1979).

Caine M. , Raz S. , Zeigler M. : Adrenergic and cholinergic receptors in the human prostate, prostatic capsule and bladder neck. Brit. J. Urol., 47; 193–202 (1975).

Finkbeiner A. E. , Bissada N. K. , Welch L. T. : Uropharmacology: V. Choline esters and other parasympathomimetic drugs. Urology, 10; 83–89 (1977).

Geller J. , Nelson C. G. , Albert J. D. , Pratt C. : Effect of Megestrol acetate on uroflow rates in patients with benign prostatic hypertrophy. Double-blind study. Urol., 14; (1979).

Grasso M. , Ronchi F. , Lania C. , Di Girolamo V. : In vitro effect of nicergoline on the contractibility of human bladder neck. Farmaco, 37; 408–410 (1982).

Khanna O. P. , Gonick P. : Effects of phenoxybenzamine hydrochloride on canine lower urinary tract: clinical implications. Urology, 6; 323–330 (1975).

Khanna O. P. : Disorders of micturition: neuropharmacological basis and results of drug treatment. Urology, 8; 316 (1976).

Kleeman F. J. : The physiology of the internal urinary sphincter. J. Urol., 104; 549–554 (1970).

Kleeman F. J. : Use of phenoxybenzamine poorly defined. Urology, 9; 708–709 (1977).

Krane R. J. , Olsson C. A. : Phenoxybenzamine in neurogenic bladder dysfunction. II. Clinical considerations. J. Urol., 110; 653–656 (1973).

Margonato A. , Ronchi F. , Grasso M. : Alpha-adrenergic receptor and disturbances of micturition: effect of nicergoline. Symposium International, Alpha-Bloquants et Nicergoline. Dijon, 1 et 2 Octobre 1982.

McDevitt D. G. : Adrenoceptor blocking drugs: clinical pharmacology and therapeutic use. Drugs, 17; 267–288 (1979).

Rohner T. J. , Raezer D. M. , Wein J. A. , Schoenberg H. W. : Contractile responses of dog bladder neck muscle to adrenergic drugs. J. Urol., 105; 657–661 (1971).

Ronchi F. , Margonato A. , Ceccardi R. , Rigatti P. , Rossini R. M. : Symptomatic treatment of BPH with nicergoline: a placebo controlled clinical study and urodynamic evaluation. Urol. Res., 10; 131–134 (1982).

Schulman C. C. , Chantrie M. , Giannakopoulos X. , De Sloover C. R. : Le traitment médical de l'adénome prostatique. Bruxelles Médical, 59 (1979).

Scott M. B. , Morrow J. W. : Phenoxybenzamine in neurogenic bladder dysfunction after spinal cord injury. II. Autonomic dysreflexia. J. Urol., 119; 483–487 (1978).

Segre G. : Farmacologia del betanecolo. Simposio nazionale sulla farmacologia del betanecolo, Gubbio 1978.

Shapiro A. , Mazouz B. , Caine M. : The Alpha-adrenergic blocking effect of Prazosin on the human prostate. Urol. Res., 9; 17–20 (1981).

Vignoli G. C. , Martelli A. : I mediatori chimici del riflesso minzionale. Simposio nazionale sulla farmacologia del betanecolo, Gubbio 1978.